Useful External Websites
Confronting Pancreatic Cancer Provides information about pancreatic cancer, including treatment, clinical trials and news stories. Pancreatic Cancer Action Network A pancreatic cancer advocacy group....

News stories relevant to the diagnosis and treatment of pancreatic cancer.

Metabolite-Based Test May Detect Early Pancreatic Cancer
Apr 1, 2013 - A test that measures four serum metabolites can accurately distinguish patients with pancreatic cancer from healthy people and patients with pancreatitis, according to a study published online March 29 in Cancer Epidemiology, Biomarkers & Prevention.

Long-Term Type 2 Diabetes Ups Pancreatic Cancer Mortality
Aug 16, 2012 - Among patients with pancreatic adenocarcinoma, those with pre-existing type 2 diabetes mellitus for longer than five years have an increased mortality risk, according to a study published online Aug. 1 in Cancer.

Selenium, Vitamins C, E May Lower Pancreatic Cancer Risk
Jul 27, 2012 - Higher intakes of the antioxidants selenium and vitamins C and E reduce the risk of pancreatic cancer by two-thirds, according to a study published online July 23 in Gut.

Coverage from professional conferences on research relevant to pancreatic cancer.

Adjuvant Chemoradiation Therapy after Surgical Resection for 1092 Cases of Pancreatic Adenocarcinoma: The Johns Hopkins Hospital - Mayo Clinic Collaborative Study of Pancreatic Cancer
Presenter: C. C. HsuPresenter's Affiliation: Johns Hopkins Hospital, Baltimore, MDType of Session: ScientificBackground Despite aggressive multimodality treatment, pancreatic cancer is associated with a high rate of mortality. Even the 15-20% of patients who present with resectable disease experience 5-year survivals of only 10-25%.

A phase III study of gemcitabine in combination with 5-FU vs. gemcitabine alone in patients with advanced pancreatic carcinoma (E2297): an Eastern Cooperative oncology Group (ECOG) trial
Presenter: J. Berlin Affiliation: ECOG, USA Background: The vast majority of patients with pancreatic cancer are diagnosed with locally advanced unrespectable or advanced disease for which there is no curative therapy. Many chemotherapeutic agents have been evaluated in patients with pancreatic cancer. Gemcitabine (gem) and 5-FU are the

Gemcitabine-Oxaliplatin (GEMOX) combination in advanced pancreatic carcinoma (APC): a Gercor Multicenter phase II study
Presenter: C. Louvet Affiliation: Hospital St-Antoine, Paris France Background: Gemcitabine has been shown to be an active agent in the treatment of pancreatic cancer. Some preclinical data showed that the combination of gemcitabine with oxaliplatin (GEMOX) exerts potent antiproliferative effects in human cancer cell lines, including

NCI CANCERLIT^® Search: Therapy of Pancreatic Cancer - October 2001
Targeted therapies for killing tumor cells. A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Evaluation of gastroenteric bypass for unresectable pancreatic cancer. Modified Devine exclusion for...

NCI CANCERLIT^® Search: Therapy of Pancreatic Cancer - September 2001
Table of Contents[Laparoscopic left pancreas resection in tumors. Initial clinical experiences][Surgical palliation of pancreatic carcinoma. Results of a 7 year period]Gene therapy for pancreatic cancer--current and prospective...

NCI CANCERLIT^® Search: Therapy of Pancreatic Cancer - April 2002
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas: great logic, grim reality. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Localized adenocarcinoma of the pancreas: the rationale for...